IMMUNOGLOBULIN G1 ANTI-(HUMAN CD33 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HUM195 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HUM195 .KAPPA.-CHAIN, DIMER
Anemia, Refractory, With Excess of Blasts
M.D. Anderson Cancer Centermonoclonal_antibodyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
33 Active assets in the Anemia, Refractory, With Excess of Blasts cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cytosin-Arabinosid University of Southern California | Phase 3 | BBB |
Fludarabine Fred Hutchinson Cancer Center | Phase 3 | BB |
CYCLOSPORIN A Fred Hutchinson Cancer Center | Phase 2 | BB |
TACROLIMUS Fred Hutchinson Cancer Center | Phase 2 | BB |
ETOPOSIDE M.D. Anderson Cancer Center | Phase 3 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G1 ANTI-(HUMAN CD33 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HUM195 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HUM195 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →